Prudential Financial Inc Viking Therapeutics, Inc. Transaction History
Prudential Financial Inc
- $70 Billion
- Q3 2024
A detailed history of Prudential Financial Inc transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 48,600 shares of VKTX stock, worth $1.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
48,600
Previous 67,446
27.94%
Holding current value
$1.7 Million
Previous $3.58 Million
13.96%
% of portfolio
0.0%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding VKTX
# of Institutions
469Shares Held
63.2MCall Options Held
5.76MPut Options Held
3.39M-
Vanguard Group Inc Valley Forge, PA10.2MShares$355 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$210 Million0.01% of portfolio
-
State Street Corp Boston, MA4.67MShares$163 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.12MShares$73.8 Million0.01% of portfolio
-
Morgan Stanley New York, NY1.87MShares$65.4 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $2.68B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...